The New York-based AI biotech will use its AMICA-OS platform to analyze clinical immune data for BMS, aiming to inform patient stratification, biomarkers, and trial decisions.
Immunai, an AI biotech company specializing in mapping the human immune system, has announced a strategic collaboration with ...
Harald Hampel is recognized as an influential leader in neuroscience, and will bring expertise in Alzheimer's disease to BMS.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback